Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya (STOP MiP KENYA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Centers for Disease Control and Prevention
Liverpool School of Tropical Medicine
London School of Hygiene and Tropical Medicine
Information provided by (Responsible Party):
Abraham Katana, MD, Kenya Medical Research Institute
ClinicalTrials.gov Identifier:
NCT01669941
First received: August 15, 2012
Last updated: August 5, 2015
Last verified: August 2015